These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 15999368)
1. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement. Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K; Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368 [TBL] [Abstract][Full Text] [Related]
2. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765 [TBL] [Abstract][Full Text] [Related]
3. CD56+ lymphoma with skin involvement: clinicopathologic features and classification. Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371 [TBL] [Abstract][Full Text] [Related]
4. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062 [TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900 [TBL] [Abstract][Full Text] [Related]
6. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement. Liu XY; Atkins RC; Feusner JH; Rowland JM Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822 [TBL] [Abstract][Full Text] [Related]
7. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients. Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082 [TBL] [Abstract][Full Text] [Related]
8. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation. Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419 [TBL] [Abstract][Full Text] [Related]
9. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment. Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas. Kojima H; Mukai HY; Shinagawa A; Yoshida C; Kamoshita M; Komeno T; Hasegawa Y; Yamashita Y; Mori N; Nagasawa T Int J Hematol; 2000 Dec; 72(4):477-83. PubMed ID: 11197216 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940 [TBL] [Abstract][Full Text] [Related]
13. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996 [TBL] [Abstract][Full Text] [Related]
14. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148 [TBL] [Abstract][Full Text] [Related]
15. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia). Zhang K; Prichard JW; Brown RE Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521 [TBL] [Abstract][Full Text] [Related]
16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm. Agliano A; Martin-Padura I; Marighetti P; Gregato G; Calleri A; Prior C; Redrado M; Calvo A; Bertolini F Clin Cancer Res; 2011 Oct; 17(19):6163-73. PubMed ID: 21856771 [TBL] [Abstract][Full Text] [Related]
19. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China. Yu JB; Zuo Z; Tang Y; Zhao S; Zhang YC; Bi CF; Wang WY; Zhang WY; Wang L; Liu WP Hum Pathol; 2009 Jun; 40(6):807-16. PubMed ID: 19200574 [TBL] [Abstract][Full Text] [Related]